Literature DB >> 2965811

A one year follow-up study of the distribution of 14C-clodronate in mice and rats.

J Mönkkönen1.   

Abstract

The distribution of 14C-clodronate (dichloromethylene bisphosphonate) was studied in mice and rats by whole-body autoradiography and by measuring the 14C-activities in various tissues up to one year after a single intravenous dose. The results indicate that the deposition of clodronate in bone tissue of mice and rats is extremely strong and long lasting; in both animals, high radioactivities were measured even 12 months after the administration. In spleen, thymus, and small intestine of mice, 14C-activity could be detected 12 months after dosing. Small amounts of radioactivity were also detected in spleen of rats for 12 months, although much less than in spleen of mice. The results suggest that clodronate accumulates to some extent in the reticuloendothelial system of animals. They suggest further than the animal species should be carefully considered when interpreting the distribution kinetics of bisphosphonates, especially their accumulation in the reticuloendothelial system.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2965811     DOI: 10.1111/j.1600-0773.1988.tb01843.x

Source DB:  PubMed          Journal:  Pharmacol Toxicol        ISSN: 0901-9928


  7 in total

Review 1.  Bisphosphonates. Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease.

Authors:  H Fleisch
Journal:  Drugs       Date:  1991-12       Impact factor: 9.546

2.  The tissue distribution of clodronate (dichloromethylene bisphosphonate) in mice. The effects of vehicle and the route of administration.

Authors:  J Mönkkönen; P Ylitalo
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Jul-Sep       Impact factor: 2.441

Review 3.  Drugs used in the treatment of metabolic bone disease. Clinical pharmacology and therapeutic use.

Authors:  S Patel; A R Lyons; D J Hosking
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

4.  Clodronate increases the calcium content in fracture callus. An experimental study in rats.

Authors:  M T Nyman; P Paavolainen; T S Lindholm
Journal:  Arch Orthop Trauma Surg       Date:  1993       Impact factor: 3.067

Review 5.  Ibandronate in osteoporosis: preclinical data and rationale for intermittent dosing.

Authors:  Frieder Bauss; R Graham G Russell
Journal:  Osteoporos Int       Date:  2004-03-26       Impact factor: 4.507

Review 6.  Etidronic acid. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.

Authors:  C J Dunn; A Fitton; E M Sorkin
Journal:  Drugs Aging       Date:  1994-12       Impact factor: 3.923

Review 7.  Clodronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.

Authors:  G L Plosker; K L Goa
Journal:  Drugs       Date:  1994-06       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.